BIOMERICA INC

BMRA

BIOMERICA INC

BMRA

Insider Sentiment (TTM):

Last Purchase:2023-05-25Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:108,130Shares Outstanding:3,010,308Institutional Ownership Pct.:3.59%

Earnings Market Reaction:

Filing Date:2026-04-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in In Vitro & In Vivo Diagnostic Substances

IDXX LNTH NEOG NTLA QDEL MYGN

BIOMERICA INC (BMRA) — SEC Financial Statements & Analysis

BIOMERICA INC (BMRA) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31	2024-05-31	2024-02-29	2023-11-30	2023-08-31	2023-05-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1	3	3	2	3	2	3	4	5	7	8	10
Accounts Receivable Net Current	1	1	1	1	1	1	2	1	1	1	1	1
Inventory Net	2	2	1	1	2	2	2	2	2	2	2	2
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	4	5	6	5	6	6	6	8	9	10	12	13
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	1	1	1	1	1	1	1	1
Investments	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	5	6	7	6	7	7	8	9	10	12	13	14
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	1	1	1	1	1	1	1	1	1	1	1	1
Employee Related Liabilities Current	1	1	1	1	1	1	1	1	1	1	1	1
Contract With Customer Liability	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	2	2	2	2	2	2	2	2	2	2	2	2
Operating Lease Liability Noncurrent	-	-	0	0	0	0	0	0	1	1	1	1
Liabilities	2	2	2	2	2	2	3	3	3	2	2	3
Stockholders Equity
Common Stock Value	0	0	0	0	2	1	1	0	1	1	1	1
Additional Paid In Capital	59	59	58	57	56	54	54	55	53	53	53	53
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-56	-54	-53	-53	-52	-50	-50	-48	-47	-45	-43	-42
Stockholders Equity	3	4	5	4	6	5	5	7	8	9	11	12
Liabilities And Stockholders Equity	5	6	7	6	7	7	8	9	10	12	13	14
Accumulated Depreciation Depletion And Amortizatio…	-	-	-	-	1	1	-	-	-	-	-	-
Finite Lived Intangible Assets Accumulated Amortiz…	0	0	0	0	0	0	0	0	0	-	-	0
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	4	4	4	4	4	4	4	4	4	4	4	4
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08
Common Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Common Stock Shares Issued	21	21	20	20	20	18	17	17	17	17	17	17
Shares Outstanding	3	3	3	3	2	2	2	2	2	2	2	2

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-14.58%	-18.75%	-12.15%	-16.67%	-28.89%	-19.63%	6.73%	1.92%	-15.87%	-	-	-
2025	21.87%	-9.38%	6.25%	57.58%	93.94%	51.52%	-18.64%	-23.18%	-25.68%	-7.99%	-4.79%	-23.00%
2024	14.67%	24.00%	66.67%	-3.12%	13.54%	-12.50%	-32.53%	-30.12%	-46.99%	-39.13%	-30.43%	-23.91%
2023	-	-	-	-	-	-	-13.69%	-25.00%	-19.05%	-4.35%	-35.65%	-17.39%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31	2024-05-31	2024-02-29	2023-11-30	2023-08-31	2023-05-31
Liquidity Ratios
Current Ratio	2.64	3.25	3.48	2.80	3.76	3.17	3.00	3.51	4.44	5.63	6.63	6.58
Quick Ratio	1.46	2.18	2.52	1.80	2.62	1.97	2.03	2.32	3.24	4.50	5.39	5.37
Working Capital	2.56M	3.59M	4.21M	3.14M	4.56M	4.07M	4.29M	5.53M	6.86M	8.44M	9.83M	10.85M
Leverage & Debt
Debt to Equity	0.47	0.36	0.33	0.45	0.33	0.42	0.47	0.40	0.32	0.26	0.23	0.23
Debt Ratio	0.32	0.26	0.25	0.31	0.25	0.30	0.32	0.29	0.25	0.21	0.19	0.19
Efficiency & Turnover
Asset Turnover TTM	0.71	0.67	0.66	0.70	0.64	0.58	0.52	0.46	0.58	0.51	0.45	0.41
Days Sales Outstanding TTM	93.19	93.05	102.98	57.66	77.05	78.29	98.75	56.25	63.62	63.61	79.61	51.14
Receivables Turnover TTM	3.92	3.92	3.54	6.33	4.74	4.66	3.70	6.49	5.74	5.74	4.58	7.14
Per Share Metrics
Diluted EPS TTM	-1.39	-1.38	-1.39	-2.16	-2.02	-2.62	-2.93	-2.84	-3.02	-2.89	-2.95	-4.04
Free Cash Flow Per Share TTM	-1.06	-1.02	-1.06	-1.69	-1.79	-2.36	-2.41	-2.58	-2.53	-2.49	-2.68	-3.13
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	4.25%	5.54%	12.96%	9.38%	13.52%	10.76%	8.86%	11.28%	11.41%	16.11%	16.86%	8.35%
Operating Profit Margin TTM	-123.79%	-118.15%	-100.06%	-96.72%	-89.75%	-105.56%	-118.04%	-117.58%	-123.49%	-115.04%	-117.91%	-135.29%
Net Profit Margin TTM	-96.49%	-90.29%	-74.84%	-93.64%	-85.39%	-100.48%	-111.85%	-110.40%	-117.44%	-110.56%	-114.50%	-133.73%
Growth Metrics
Net Revenue Growth (1Y)	-23.84%	-20.08%	-11.35%	-1.92%	5.07%	1.42%	1.74%	1.42%	-43.28%	-65.80%	-71.86%	-71.71%
Net Income Growth (1Y)	-13.94%	-28.19%	-40.68%	-16.81%	-23.61%	-7.83%	-0.61%	-16.27%	-10.67%	9.35%	22.52%	57.58%
EPS Growth (1Y)	-31.44%	-47.15%	-52.72%	-23.83%	-33.02%	-9.44%	-0.63%	-29.57%	-28.40%	-12.54%	-4.58%	41.09%
Valuation Metrics
P/E TTM	-1.50	-1.71	-2.26	-1.41	-2.89	-1.19	-1.20	-1.63	-3.23	-2.57	-3.47	-2.72
P/B	1.89	1.55	1.60	1.71	2.53	1.31	1.38	1.48	2.63	1.67	2.00	1.65
P/S TTM	1.45	1.55	1.69	1.32	2.47	1.20	1.34	1.80	3.80	2.84	3.98	3.63
Market Cap	6.26M	6.89M	8.26M	7.01M	14.01M	6.68M	7.40M	9.76M	20.52M	15.64M	21.53M	19.39M
Enterprise Value	4.93M	4.35M	5.21M	4.61M	10.95M	4.31M	4.58M	5.59M	15.20M	8.51M	13.54M	9.67M
Calculated Values
Free Cash Flow TTM	-3.19M	-2.97M	-2.80M	-3.88M	-4.29M	-5.05M	-5.08M	-5.43M	-5.32M	-5.24M	-5.63M	-5.54M
Net Debt	-1.34M	-2.54M	-3.05M	-2.40M	-3.06M	-2.37M	-2.82M	-4.17M	-5.32M	-7.13M	-7.99M	-9.72M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-05-25Purchase

Owner: Irani, Zackary S.

Title: Chief Executive Officer

Shares: 200

Price/Share: $1.55

Value: $310.00

Shares Owned: 1,020,560

Relationship: Director,Officer

Ownership: Direct

2023-05-12Purchase

Owner: Irani, Zackary S.

Title: Chief Executive Officer

Shares: 1,700

Price/Share: $1.17

Value: $1,989.00

Shares Owned: 1,019,860

Relationship: Director,Officer

Ownership: Direct

2023-05-10Purchase

Owner: Irani, Zackary S.

Title: Chief Executive Officer

Shares: 500

Price/Share: $1.27

Value: $635.00

Shares Owned: 1,018,160

Relationship: Director,Officer

Ownership: Direct

2023-05-09Purchase

Owner: Irani, Zackary S.

Title: Chief Executive Officer

Shares: 300

Price/Share: $1.39

Value: $417.00

Shares Owned: 1,017,660

Relationship: Director,Officer

Ownership: Direct

2023-05-04Purchase

Owner: Irani, Zackary S.

Title: Chief Executive Officer

Shares: 1,000

Price/Share: $1.36

Value: $1,360.00

Shares Owned: 1,017,360

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-05-25	Irani, Zackary S.	Director,Officer	Chief Executive Officer	Direct	Purchase	200	1.55	$310.00	1,020,560	4
2023-05-12	Irani, Zackary S.	Director,Officer	Chief Executive Officer	Direct	Purchase	1,700	1.17	$1,989.00	1,019,860	4
2023-05-10	Irani, Zackary S.	Director,Officer	Chief Executive Officer	Direct	Purchase	500	1.27	$635.00	1,018,160	4
2023-05-09	Irani, Zackary S.	Director,Officer	Chief Executive Officer	Direct	Purchase	300	1.39	$417.00	1,017,660	4
2023-05-04	Irani, Zackary S.	Director,Officer	Chief Executive Officer	Direct	Purchase	1,000	1.36	$1,360.00	1,017,360	4
2023-04-28	Irani, Zackary S.	Director,Officer	Chief Executive Officer	Direct	Purchase	1,800	1.34	$2,412.00	1,017,360	4
2023-04-26	Irani, Zackary S.	Director,Officer	Chief Executive Officer	Direct	Purchase	7,000	1.26	$8,820.00	1,012,960	4
2023-01-27	Barbieri, Allen	Director,Officer	Executive Vice Chairman	Direct	Purchase	1,538	2.94	$4,521.72	101,327	4
2023-01-26	Coste, Catherine	Director,Other	-	Direct	Purchase	2,190	2.96	$6,482.40	43,790	4
2023-01-25	Irani, Zackary S.	Director,Officer	Chief Executive Officer	Direct	Purchase	1,800	2.85	$5,130.00	1,005,960	4
2023-01-24	Irani, Zackary S.	Director,Officer	Chief Executive Officer	Direct	Purchase	2,000	2.81	$5,620.00	1,004,160	4
2020-10-26	Coste, Catherine	Director	-	Indirect	Purchase	9,100	5.45	$49,595.00	9,100	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

3.59%

Inst. Shares: 108,130

Shares Outstanding: 3,010,308

2025-12-31

3.08%

Inst. Shares: 89,452

Shares Outstanding: 2,908,164

2025-09-30

3.37%

Inst. Shares: 88,795

Shares Outstanding: 2,638,699

2025-06-30

3.03%

Inst. Shares: 69,494

Shares Outstanding: 2,297,057

2025-03-31

4.87%

Inst. Shares: 116,746

Shares Outstanding: 2,398,285

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	108,130	3,010,308	3.59%
2025-12-31	89,452	2,908,164	3.08%
2025-09-30	88,795	2,638,699	3.37%
2025-06-30	69,494	2,297,057	3.03%
2025-03-31	116,746	2,398,285	4.87%
2024-12-31	167,743	2,140,179	7.84%
2024-09-30	192,538	2,103,154	9.15%
2024-06-30	264,200	2,103,154	12.56%
2024-03-31	462,262	2,102,706	21.98%
2023-12-31	464,015	2,102,706	22.07%
2023-09-30	490,156	2,102,706	23.31%
2023-06-30	540,827	1,769,284	30.57%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

BIOMERICA INC (BMRA) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.